Zuga Matt
- SEC CIK
- 0001790214
In the past year, 3 open-market sale filings worth $49.6K and no purchases.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.CFO & Chief Business Officeras of Jan 23, 2026
- ELUT Elutia Inc.Director, 10% Owneras of Jun 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $49.6K
- 3 filings
- Net
- −$49.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zuga Matt as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ABOS Acumen Pharmaceuticals, Inc.
CFO & Chief Business Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 (view filing) | Jan 21-22 | 2 days | Zuga MattCFO & Chief Business Officer | SSale | −4.16K | $1.83 | −$7.61K | −1.3%304.9K after | 2 lots |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Zuga MattCFO & Chief Business Officer | SSale | −6.89K | $1.82 | −$12.5K | −3.2%210.0K after | |
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Zuga MattCFO & Chief Business Officer | SSale | −14.9K | $1.98 | −$29.5K | −6.4%216.8K after | 4 lots |
| Jan 23, 2025 (view filing) | Jan 21-23 | 2 days | Zuga MattCFO & Chief Business Officer | SSale | −33.3K | $1.70 | −$56.7K | −12.6%231.7K after | 2 lots10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Zuga MattCFO & Chief Business Officer | SSale | −13.2K | $1.84 | −$24.4K | −6.3%198.2K after | 10b5-1 |
| Jan 19, 2024 (view filing) | Jan 18 | 1 day | Zuga MattCFO & Chief Business Officer | SSale | −4.24K | $3.71 | −$15.7K | −2.0%211.4K after | 10b5-1 |
ELUT Elutia Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 (view filing)4:28 PM ET | Feb 3 | 38 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +420.0K | $2.50 | +$1.05M | +4.6%9.52M after | |
| Oct 5, 2023 (view filing)4:43 PM ET | Sep 21, 2021 | 744 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +2.84M | – | – | +50.7%8.43M after | |
| Oct 5, 2023 (view filing)4:43 PM ET | Sep 21, 2021 | 744 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +4.26M | – | – | –4.26M after | Derivative |
| Dec 7, 2022 (view filing)4:31 PM ET | Dec 5 | 2 days | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +735.0K | $4.75 | +$3.49M | +15.1%5.60M after | |
| Dec 10, 2021 (view filing)4:22 PM ET | Dec 8 | 2 days | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +412.7K | $4.24 | +$1.75M | New position90.8K after | 2 lots |